{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T23:33:42Z","timestamp":1779233622450,"version":"3.51.4"},"reference-count":40,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2001,12,24]],"date-time":"2001-12-24T00:00:00Z","timestamp":1009152000000},"content-version":"vor","delay-in-days":479,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2000,9]]},"abstract":"<jats:p>The difference in the current cure rates between adult and childhood acute lymphoblastic leukaemia (ALL) may be caused by differences in drug resistance. Earlier studies showed that <jats:italic>in vitro<\/jats:italic> cellular drug resistance is a strong independent adverse risk factor in childhood ALL. Knowledge about cellular drug resistance in adult ALL is still limited. The present study compared the <jats:italic>in vitro<\/jats:italic> drug resistance profiles of 23 adult ALL patients with that of 395 childhood ALL patients. The lymphoblasts were tested by the MTT assay. The group of adult ALL samples was significantly more resistant to cytosine arabinoside, \n\t\t\t\t\t<jats:sc>l<\/jats:sc>\u2010asparaginase, daunorubicin, dexamethasone and prednisolone. The resistance ratio (RR) was highest for prednisolone (31\u00b77\u2010fold) followed by dexamethasone (6\u00b79\u2010fold), \n\t\t\t\t\t<jats:sc>l<\/jats:sc>\u2010asparaginase (6\u00b71\u2010fold), cytosine arabinoside (2\u00b79\u2010fold), daunorubicin (2\u00b75\u2010fold) and vincristine (2\u00b72\u2010fold). Lymphoblasts from adult patients were not more resistant to mercaptopurine, thioguanine, 4\u2010HOO\u2010ifosfamide, mitoxantrone and teniposide. There were no significant differences in drug resistance between adult T\u2010cell (T\u2010) ALL (<jats:italic>n<\/jats:italic>\u2003=\u200311) and adult common\/pre\u2010B\u2010cell (B\u2010) ALL (<jats:italic>n<\/jats:italic>\u2003=\u200310). Additionally, adult T\u2010ALL did not differ from childhood T\u2010ALL (<jats:italic>n<\/jats:italic>\u2003=\u200369). There were significant differences between adult common\/pre\u2010B\u2010ALL and childhood common\/pre\u2010B\u2010ALL (<jats:italic>n<\/jats:italic>\u2003=\u2003310) for prednisolone (RR\u2003=\u2003302, <jats:italic>P<\/jats:italic>\u2003=\u20030\u00b7008), dexamethasone (RR\u2003=\u200320\u00b79, <jats:italic>P<\/jats:italic>\u2003=\u20030\u00b7017) and daunorubicin (RR\u2003=\u20032\u00b77, <jats:italic>P<\/jats:italic>\u2003=\u20030\u00b7009). Lymphoblasts from adults proved to be relatively resistant to drugs commonly used in therapy. This might contribute to the difference in outcome between children and adults with ALL.<\/jats:p>","DOI":"10.1046\/j.1365-2141.2000.02211.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T06:28:31Z","timestamp":1047364111000},"page":"813-818","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["<i>In vitro<\/i> drug resistance profiles of adult versus childhood acute lymphoblastic leukaemia"],"prefix":"10.1111","volume":"110","author":[{"given":"Jan","family":"Styczynski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rob","family":"Pieters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dieuwke R.","family":"Huismans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerrit J.","family":"Schuurhuis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariusz","family":"Wysocki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anjo J. P.","family":"Veerman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2001,12,24]]},"reference":[{"key":"e_1_2_6_2_1","first-page":"491","article-title":"Involvement of Bcl\u20102 in glucocorticoid\u2010induced apoptosis of human pre\u2010B\u2010leukemias","volume":"52","author":"Alnemri E.S.","year":"1992","journal-title":"Cancer Research"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V81.9.2215.2215"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1097\/00043426-199901000-00003"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(94)90023-X"},{"key":"e_1_2_6_6_1","first-page":"49a","article-title":"Hyperdiploid acute lymphoblastic leukemia (ALL): a distinct biologic entity with marked propensity to programmed cell death","volume":"82","author":"Campana D.","year":"1993","journal-title":"Blood"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2400959"},{"key":"e_1_2_6_8_1","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1182\/blood.V85.5.1151.bloodjournal8551151","article-title":"The biology and treatment of acute lymphoblastic leukemia in adults","volume":"85","author":"Copelan E.A.","year":"1995","journal-title":"Blood"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19951215)76:12<2393::AID-CNCR2820761203>3.0.CO;2-P"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401175"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(94)90518-5"},{"key":"e_1_2_6_12_1","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1182\/blood.V81.9.2394.2394","article-title":"Expression of the multidrug resistance\u2010associated P\u2010glycoprotein (P\u2010170) in 59 cases of de novo acute lymphoblastic leukemia: prognostic implications","volume":"81","author":"Goasguen J.E.","year":"1993","journal-title":"Blood"},{"key":"e_1_2_6_13_1","first-page":"1000","article-title":"Decreased polyglutamylation of methotrexate in ALL blasts in adults compared to children with this disease","volume":"7","author":"Goker E.","year":"1993","journal-title":"Leukemia"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1993.81"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199310283291810"},{"key":"e_1_2_6_16_1","first-page":"12","article-title":"Aggressive chemotherapy of ALL in elderly patients","volume":"1","author":"Hoelzer D.","year":"1993","journal-title":"Haematological Oncology"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428199809058629"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V89.8.2959"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1994.446"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428199409056282"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V85.3.751.bloodjournal853751"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V90.7.2723"},{"key":"e_1_2_6_23_1","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1182\/blood.V92.1.259.413k21_259_266","article-title":"Prednisolone resistance in childhood acute lymphoblastic leukemia: vitro\u2013vivo correlations and cross\u2010resistance to other drugs","volume":"92","author":"Kaspers G.J.L.","year":"1998","journal-title":"Blood"},{"key":"e_1_2_6_24_1","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1182\/blood.V80.7.1788.1788","article-title":"Clonal evolution in a myeloid cell line transformed to interleukin\u20103 independent growth by retroviral transduction and expression of p210 bcr\/abl","volume":"80","author":"Laneuville P.","year":"1992","journal-title":"Blood"},{"key":"e_1_2_6_25_1","first-page":"70","article-title":"Treatment of adult acute lymphoblastic leukemia","volume":"24","author":"Laport G.F.","year":"1997","journal-title":"Seminars in Oncology"},{"key":"e_1_2_6_26_1","unstructured":"Larson R.A. Stock W. Hoelzer D.F. Kantarijan H.(1998)Acute lymphoblastic leukemia in adults. In:Hematology 1998 pp.4562. Amgen The American Society of Hematology Congress 1998."},{"key":"e_1_2_6_27_1","first-page":"S24","article-title":"Risk adapted treatment of adult acute lymphoblastic leukemia (ALL)","volume":"11","author":"Linker C.A.","year":"1997","journal-title":"Leukemia"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1995.tb05251.x"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1097\/00062752-199603040-00003"},{"key":"e_1_2_6_30_1","first-page":"S4","article-title":"Why is age such an important independent prognostic factor in acute lymphoblastic leukemia?","volume":"11","author":"Parentesis J.P.","year":"1997","journal-title":"Leukemia"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3835(88)90294-7"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1989.44"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(91)91029-T"},{"key":"e_1_2_6_34_1","first-page":"392","article-title":"Cellular drug resistance profiles that might explain the prognostic value of immunophenotype and age in childhood acute lymphoblastic leukemia","volume":"7","author":"Pieters R.","year":"1993","journal-title":"Leukemia"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401129"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.1097\/00062752-199603040-00002"},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199808273390907"},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401258"},{"key":"e_1_2_6_39_1","first-page":"195b","article-title":"Measurement of drug\u2010induced apoptosis for the assessment of in vitro drug sensitivity in childhood aute leukemia: a new approach (Abstract)","volume":"92","author":"Savasan S.","year":"1998","journal-title":"Blood"},{"key":"e_1_2_6_40_1","first-page":"1870","article-title":"Expression of the multidrug resistance P glycoprotein in newly diagnosed adult acute lympoblastic leukemia: absence of correlation with response to treatment","volume":"9","author":"Wattle E.","year":"1995","journal-title":"Leukemia"},{"key":"e_1_2_6_41_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01757352"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.2000.02211.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.2000.02211.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2141.2000.02211.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,29]],"date-time":"2023-10-29T17:29:57Z","timestamp":1698600597000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2141.2000.02211.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,9]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2000,9]]}},"alternative-id":["10.1046\/j.1365-2141.2000.02211.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2141.2000.02211.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,9]]},"assertion":[{"value":"2001-12-24","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}